Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

Kristian Reich, April W. Armstrong, Richard G. Langley, Susan Flavin, Bruce Randazzo, Shu Li, Ming Chun Hsu, Patrick Branigan, Andrew Blauvelt

科研成果: 期刊稿件 › 文章 › 同行评审

268 引用 （Scopus）

指纹

探究 'Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial' 的科研主题。它们共同构成独一无二的指纹。

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science